Skip to Content

Focetria

Active Substance: Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose
Common Name: influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted)
ATC Code: J07BB02
Marketing Authorisation Holder: Novartis Vaccines and Diagnostics S.r.l.
Active Substance: Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose
Status: Withdrawn
Authorisation Date: 2007-05-02
Therapeutic Area: Influenza, Human Immunization Disease Outbreaks
Pharmacotherapeutic Group: Influenza vaccines

Therapeutic Indication

Prophylaxis of influenza caused by A (H1N1v) 2009 virus.

Focetria should be used in accordance with official guidance.

The marketing authorisation for Focetria has been expired following the marketing-authorisation holder's decision not to apply for a renewal.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide